Close Menu

NEW YORK (GenomeWeb News) — WaferGen Biosystems and Qiagen KK, the Japanese subsidiary of Qiagen, said today that they have inked a co-marketing agreement for genomics products.

Under the agreement, Qiagen and WaferGen will promote each other's products in Japan. In particular, the companies will co-market WaferGen's SmartChip Real-Time PCR system and Qiagen's PCR arrays and next-generation sequencing platform, the latter of which is currently in an "advanced stage of development," the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24
Sponsored by
Sunquest

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.